The cost–effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care-Reference-Cited by-同舟云学术

The cost–effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care

Published:2014-12-23 Issue:1 Volume:15 Page:125-136
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Hendriksen Janneke MT,Geersing Geert-Jan,van Voorthuizen Suzanne C,Oudega Ruud,ten Cate-Hoek Arina J,Joore Manuela A,Moons Karel GM,Koffijberg Hendrik

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737159.2015.976202

Reference42 articles.

1. The Epidemiology of Venous Thromboembolism

2. Preventing pulmonary embolism and deep vein thrombosis: a ?call to action? for vascular medicine specialists

3. Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of Deep Venous Thrombosis

4. Safely Ruling Out Deep Venous Thrombosis in Primary Care

5. Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism;Thrombosis Research;2023-12

2. Point-of-Care Testing in the Diagnosis of Deep Vein Thrombosis: A Review;IEEE Systems, Man, and Cybernetics Magazine;2023-04

3. Clinical aspects of snakebite envenoming and its treatment in low-resource settings;The Lancet;2023-04

4. Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysis;BMC Primary Care;2023-02-07

5. Clinical decision rules in primary care: necessary investments for sustainable healthcare;Primary Health Care Research & Development;2023